GeneSight® Mental Health Monitor Results
Myriad Genetics
MAY 20, 2025
Myriad Genetics has been conducting the GeneSight Mental Health Monitor surveys since 2020 to learn about American attitudes towards mental health and related issues. The majority of these patients (54%) agree that genetic testing for mental health medications (known as pharmacogenomic or PGx testing) could reduce these concerns.
Let's personalize your content